Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc. on September 27, 2023. Cosmos Health has determined that spinning off its R&D division into a standalone, well-capitalized, publicly listed biotech entity will best serve its shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.692 USD | -1.15% | +0.29% | -50.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.92% | 11.66M | |
+21.93% | 73.38B | |
-1.71% | 24.13B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B | |
+24.00% | 3.71B |
- Stock Market
- Equities
- COSM Stock
- News Cosmos Health Inc.
- Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc.